NIH #R01CA289885
Leveraging First Mouse Model Reproducing Human Translocation Renal Cell Carcinoma to Investigate Molecular Mechanisms
Active
- Amount
- $500K–$600K
- Period
- 2026-06-20 → 2031-05-31
- PIs
- 1
Awarded at UT SOUTHWESTERN MEDICAL CENTER
James Brugarolas
Full Professor(heuristic)
Renal cell carcinoma treatment · Pulmonary and Respiratory Medicine
Compare more Pulmonary and Respiratory Medicine professors.
h-index65
i10-index162
Publications641
Citations18,469
Grants
6 total · 1 active
NIH #R21CA263264
Dissecting the mechanism of cabozantinib anti-tumor effect in renal cancer
- Amount
- $200K–$300K
- Period
- 2021-07-02 → 2023-12-31
- PIs
- 1
Awarded at UT SOUTHWESTERN MEDICAL CENTER
NIH #P50CA196516
The University of Texas Southwestern Medical Center SPORE in Kidney Cancer
- Amount
- $2M–$3M
- Period
- 2016-08-01 → 2021-07-31
- PIs
- 1
Awarded at UT SOUTHWESTERN MEDICAL CENTER
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Recent Public Signals
- New preprint: Clear cell renal cell carcinoma consensus transcriptomic programs reveal converging trajectories towards aggressive disease2026-06-26
- New NIH award: Leveraging First Mouse Model Reproducing Human Translocation Renal Cell Carcinoma to Investigate Molecular Mechanisms2026-06-20
- New paper: Supplementary Figure 2 from HIF-2–Dependent Regulation of PTHrP and Paraneoplastic Hypercalcemia in Aggressive Clear-Cell Renal Cell Carcinoma2026-06-18
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-09-03
Data may not be current
Find elsewhere
ORCID: 0000-0002-8575-499X